Literature DB >> 16410888

Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study.

Antonio C Toledo1, Dirceu B Greco, Marcelo Felga, Dráurio Barreira, Maria de Fátima S Gadelha, Francisco A B Speranza.   

Abstract

Hepatitis B and C constitute important public health problems worldwide. In Brazil, studies on prevalence of viral hepatitis have local and regional characteristics; consequently it is difficult to define the national epidemiological situation. Our objective was to evaluate the seroprevalence of hepatitis B and C in conscripts of the Brazilian Army. A transversal study among males aged 17 to 22 years was conducted nationwide. After informed consent, each volunteer filled in a social-behavioral questionnaire and had blood drawn to test for HBsAg and anti-HCV. A total of 7,372 volunteers were evaluated in the second half of 2002. The prevalence of HBsAg was 2.6% (95% confidence interval: 2.2, 3.0) and that of anti-HCV was 1.5% (95% confidence interval: 1.2, 1.8). A wide variation among macro regions and states in the same region was observed for both markers. In conclusion, although this population theoretically had a low risk for HBV and HCV infection, these results are higher than expected for this age range. These findings may indicate a change in the pattern of HBV and HCV transmission in Brazil. Due to the different dynamics of these epidemics, further studies are warranted to confirm these apparent trends.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410888     DOI: 10.1590/s1413-86702005000500004

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  4 in total

1.  Prevalence of serological markers and risk factors for bloodborne pathogens in Salvador, Bahia state, Brazil.

Authors:  S B Matos; A L S R Jesus; K C M C Pedroza; H R S Sodre; T L H Ferreira; F W M Lima
Journal:  Epidemiol Infect       Date:  2012-03-15       Impact factor: 4.434

2.  Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.

Authors:  Hélio Ranes de Menezes Filho; Ana Luiza de Souza Bierrenbach; Maria Ligia Damato Capuani; Alfredo Mendrone; Adele Schwartz Benzaken; Soraia Mafra Machado; Marielena Vogel Saivish; Ester Cerdeira Sabino; Steven Sol Witkin; Maria Cássia Mendes-Corrêa
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

3.  A time series analysis of detection and mortality of hepatitis C in Brazil, 2008-2018.

Authors:  Rodrigo José Videres Cordeiro de Brito; Leonardo Feitosa da Silva; Márcio Bezerra Santos; Patrícia Muniz Mendes Freire de Moura; Carlos Dornels Freire de Souza; Rodrigo Feliciano do Carmo
Journal:  BMC Infect Dis       Date:  2022-01-24       Impact factor: 3.090

4.  Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach.

Authors:  Adele Schwartz Benzaken; Renato Girade; Elisa Catapan; Gerson Fernando Mendes Pereira; Elton Carlos de Almeida; Simone Vivaldini; Neide Fernandes; Homie Razavi; Jonathan Schmelzer; Maria Lucia Ferraz; Paulo Roberto Abrão Ferreira; Mario Guimarães Pessoa; Ana Martinelli; Francisco José Dutra Souto; Nick Walsh; Maria Cassia Mendes-Correa
Journal:  Braz J Infect Dis       Date:  2019-05-27       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.